Evaluation and comparison of the effects of a new paste containing 8% L-Arginine and CaCO3 plus KNO3 on dentinal tubules occlusion and dental sensitivity: a randomized, triple blinded clinical trial study.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
29 Apr 2024
Historique:
received: 31 01 2024
accepted: 26 04 2024
medline: 30 4 2024
pubmed: 30 4 2024
entrez: 29 4 2024
Statut: epublish

Résumé

Dentin hypersensitivity, often occurring after dental treatments or from erosive lesions, is a prevalent patient complaint. This study introduces a paste combining 8% L-arginine, calcium carbonate, and potassium nitrate to evaluate its impact on dentinal tubules occlusion, dentin permeability, and tooth sensitivity. Dentin surfaces from 24 third molars (thickness: 2 mm) were divided into two groups of 12. One received the experimental paste, while the other received a placebo without desensitizer. Permeability and sealing ability were assessed through scanning electron microscopy (SEM) and dentin permeability measurement. The pastes' effects on hypersensitivity were then examined in a triple-blind, randomized parallel-armed clinical trial with 16 eligible patients. Sensitivity to cold, touch, and spontaneous stimuli was recorded using the VAS scale at various intervals post-treatment. Statistical analysis was conducted using Shapiro-Wilk, Mann-Whitney U, Friedman, and Wilcoxon tests (α = 0.05). The permeability test demonstrated a significant reduction in dentin permeability in the experimental group (P = 0.002) compared to the control (P = 0.178). SEM images revealed most dentinal tubules in the intervention samples to be occluded. Clinically, both groups showed a significant decrease in the three types of evaluated sensitivity throughout the study. However, no significant difference in sensitivities between the two groups was observed, with the exception of cold sensitivity at three months post-treatment (P = 0.054). The innovative desensitizing paste featuring 8% L-arginine, calcium carbonate, and potassium nitrate effectively occluded dentinal tubules and reduced dentin permeability. It mitigated immediate and prolonged dentin hypersensitivity to various stimuli, supporting its potential role in managing dentin hypersensitivity. http://irct.ir : IRCT20220829055822N1, September 9th, 2022.

Sections du résumé

BACKGROUND BACKGROUND
Dentin hypersensitivity, often occurring after dental treatments or from erosive lesions, is a prevalent patient complaint. This study introduces a paste combining 8% L-arginine, calcium carbonate, and potassium nitrate to evaluate its impact on dentinal tubules occlusion, dentin permeability, and tooth sensitivity.
METHODS METHODS
Dentin surfaces from 24 third molars (thickness: 2 mm) were divided into two groups of 12. One received the experimental paste, while the other received a placebo without desensitizer. Permeability and sealing ability were assessed through scanning electron microscopy (SEM) and dentin permeability measurement. The pastes' effects on hypersensitivity were then examined in a triple-blind, randomized parallel-armed clinical trial with 16 eligible patients. Sensitivity to cold, touch, and spontaneous stimuli was recorded using the VAS scale at various intervals post-treatment. Statistical analysis was conducted using Shapiro-Wilk, Mann-Whitney U, Friedman, and Wilcoxon tests (α = 0.05).
RESULTS RESULTS
The permeability test demonstrated a significant reduction in dentin permeability in the experimental group (P = 0.002) compared to the control (P = 0.178). SEM images revealed most dentinal tubules in the intervention samples to be occluded. Clinically, both groups showed a significant decrease in the three types of evaluated sensitivity throughout the study. However, no significant difference in sensitivities between the two groups was observed, with the exception of cold sensitivity at three months post-treatment (P = 0.054).
CONCLUSION CONCLUSIONS
The innovative desensitizing paste featuring 8% L-arginine, calcium carbonate, and potassium nitrate effectively occluded dentinal tubules and reduced dentin permeability. It mitigated immediate and prolonged dentin hypersensitivity to various stimuli, supporting its potential role in managing dentin hypersensitivity.
TRIAL REGISTRATION BACKGROUND
http://irct.ir : IRCT20220829055822N1, September 9th, 2022.

Identifiants

pubmed: 38685035
doi: 10.1186/s12903-024-04298-3
pii: 10.1186/s12903-024-04298-3
doi:

Substances chimiques

Arginine 94ZLA3W45F
Calcium Carbonate H0G9379FGK
potassium nitrate RU45X2JN0Z
Nitrates 0
Potassium Compounds 0
Dentin Desensitizing Agents 0
Toothpastes 0

Types de publication

Journal Article Randomized Controlled Trial Comparative Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

507

Informations de copyright

© 2024. The Author(s).

Références

J Dent. 2017 May;60:36-43
pubmed: 28219674
J Adhes Dent. 2002 Fall;4(3):211-21
pubmed: 12666757
J Clin Dent. 2009;20(4):115-22
pubmed: 19831164
J Clin Dent. 2011;22(4):121-7
pubmed: 22403988
J Clin Dent. 2010;21(3):82-7
pubmed: 21207919
Clin Oral Investig. 2022 Dec;26(12):6985-6993
pubmed: 35871702
J Clin Periodontol. 2001 Nov;28(11):1032-6
pubmed: 11686824
J Dent Res. 1974 Nov-Dec;53(6):1503
pubmed: 4529945
J Dent. 2019 Sep;88:103170
pubmed: 31325467
J Clin Dent. 2009;20(1):1-9
pubmed: 19489186
J Indian Soc Periodontol. 2014 Jul;18(4):466-71
pubmed: 25210261
J Clin Dent. 2009;20(1):23-31
pubmed: 19489189
J Conserv Dent Endod. 2023 Nov-Dec;26(6):682-687
pubmed: 38292733
Caries Res. 1992;26(5):345-50
pubmed: 1468098
J Periodontol. 1980 Oct;51(10):578-81
pubmed: 7003091
J Prosthet Dent. 1984 Feb;51(2):209-13
pubmed: 6583398
Biomed Res Int. 2020 Jan 30;2020:6747498
pubmed: 32090106
Quintessence Int. 2021 Jun 9;52(7):596-605
pubmed: 33749220
J Conserv Dent Endod. 2023 Nov-Dec;26(6):702-708
pubmed: 38292739
Aust Dent J. 2012 Dec;57(4):429-34
pubmed: 23186566
J Oral Rehabil. 2019 Oct;46(10):952-990
pubmed: 31216069
J Clin Dent. 2012;23(2):40-7
pubmed: 22779216
J Orofac Pain. 2000 Winter;14(1):9-19
pubmed: 11203743
J Conserv Dent. 2013 Jul;16(4):375-9
pubmed: 23956545
Clin Oral Investig. 2020 Nov;24(11):4043-4049
pubmed: 32390092
Arch Oral Biol. 1978;23(9):807-10
pubmed: 299019
Clin Oral Investig. 2021 Jul;25(7):4311-4327
pubmed: 34075489
Clin Ther. 2012 Mar;34(3):614-22
pubmed: 22385928
J Periodontol. 2022 Feb;93(2):246-255
pubmed: 34061357
J Indian Soc Periodontol. 2021 Jul-Aug;25(4):283-287
pubmed: 34393397
J Clin Periodontol. 2015 Feb;42(2):131-41
pubmed: 25483802
J Clin Periodontol. 1997 Nov;24(11):808-13
pubmed: 9402502
J Clin Periodontol. 1989 Mar;16(3):190-5
pubmed: 2656768
J Periodontol. 1987 Jul;58(7):470-4
pubmed: 3476718
Med Oral Patol Oral Cir Bucal. 2010 Nov 01;15(6):e976-82
pubmed: 20711129
Front Dent. 2019 Sep-Oct;16(5):325-334
pubmed: 32123872
Clin Oral Investig. 2022 Feb;26(2):1299-1307
pubmed: 34351504
Clin Oral Investig. 2023 Aug;27(8):4843-4854
pubmed: 37382717
Quintessence Int. 2013 Oct;44(9):709-23
pubmed: 23878846
J Dent Res. 1997 Sep;76(9):1587-95
pubmed: 9294493
Braz Oral Res. 2020 May 8;34:e043
pubmed: 32401933
Am J Dent. 2010 May;23 Spec No A:20A-27A
pubmed: 21284248
Aust Dent J. 2006 Sep;51(3):212-8; quiz 276
pubmed: 17037886
J Conserv Dent. 2017 Jul-Aug;20(4):269-272
pubmed: 29259366
Dent Clin North Am. 1990 Jul;34(3):561-81
pubmed: 2197128
Indian J Dent Res. 2018 Jan-Feb;29(1):51-55
pubmed: 29442087
J Clin Periodontol. 2003 Apr;30(4):315-20
pubmed: 12694429
PLoS One. 2016 Jun 30;11(6):e0158400
pubmed: 27359118
Scand J Pain. 2016 Oct;13:123-124
pubmed: 28850508
J Clin Periodontol. 2001 Jan;28(1):16-22
pubmed: 11142662
J Clin Diagn Res. 2017 Apr;11(4):ZC136-ZC141
pubmed: 28571281
J Dent. 2019 Oct;89:103180
pubmed: 31415787
J Dent. 2013 Mar;41 Suppl 1:S1-11
pubmed: 23000522
J Periodontol. 2010 Aug;81(8):1167-73
pubmed: 20370417
J Periodontol. 1985 Apr;56(4):216-22
pubmed: 3889271
Am J Dent. 2010 May;23 Spec No A:28A-35A
pubmed: 21284249
Dent Clin North Am. 1990 Jul;34(3):475-90
pubmed: 2197122
J Oral Rehabil. 2001 Nov;28(11):1037-44
pubmed: 11722720
J Clin Periodontol. 1994 Mar;21(3):217-21
pubmed: 8157777
J Oral Rehabil. 2002 Feb;29(2):167-74
pubmed: 11856396
Br J Dermatol. 2019 Mar;180(3):534-552
pubmed: 30609010
J Am Dent Assoc. 2006 Jul;137(7):990-8; quiz 1028-9
pubmed: 16803826
Chin J Dent Res. 2014;17(1):43-7
pubmed: 25028689
J Family Med Prim Care. 2020 Jan 28;9(1):354-358
pubmed: 32110618
J Periodontol. 1991 Jul;62(7):421-8
pubmed: 1920008
Malays J Med Sci. 2003 Jan;10(1):27-36
pubmed: 23365497
Biochem Biophys Res Commun. 1988 Jun 30;153(3):1251-6
pubmed: 3390182
Am J Dent. 2010 May;23 Spec No A:3A-13A
pubmed: 21284246
Oral Health Prev Dent. 2019;17(5):403-412
pubmed: 31612158
Indian J Dent Res. 2017 Jul-Aug;28(4):450-456
pubmed: 28836539
Photomed Laser Surg. 2009 Oct;27(5):807-12
pubmed: 19715434
J Clin Dent. 1994;5 Spec No:87-92
pubmed: 8534380

Auteurs

Hamideh Sadat Mohammadipour (HS)

Department of Restorative and Cosmetic Dentistry, Mashhad Dental School, Mashhad University of Medical Sciences, Mashhad, Iran.

Hossein Bagheri (H)

Dental Materials Research Center, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.

Saber Babazadeh (S)

Department of Community Oral Health, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.

Mehrzad Khorshid (M)

Independent Researcher, Mashhad, Iran.

Zahra Shooshtari (Z)

Dentist, Research Assistant, Dental Research Center, Mashhad Dental School, Mashhad University of Medical Sciences, Mashhad, Iran.

Arsalan Shahri (A)

Dental Materials Research Center, Mashhad Dental School, Mashhad University of Medical Sciences, Mashhad, Iran. Arsalshahri98@gmail.com.
Mashhad dental school, Mashhad university of medical sciences university campus, P.O. Box: 9178613111, Mashhad, Iran. Arsalshahri98@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH